All of the below were in the inclusion criteria for UNIFI patients EXCEPT:
A. ≥18 years of age
B. Moderate-to-severe UC diagnosis ≥3 months before screening
C. Stable doses of 5-ASA and immunomodulators were maintained from induction BL through maintenance Week 44
D. Prior TNF-antagonist therapy was discontinued ≥8 weeks and vedolizumab ≥4 months before study entry; other conventional therapies were discontinued ≥2-4 weeks before study entry
E. Oral corticosteroids were maintained at a stable dose during induction and tapered upon entering maintenance
Select your answer:
Topics:
Nutrition Vocabulary Ankle, Foot, & LL - Injuries Cell Review Diabetes Mellitus Cell Transport Gastroenterology Human Anatomy and Physiology Medical Terminology Prefixes Proteins Psoriasis Renal, Cancer, HIV Transportation and Excretion Foot Orthosis Vocab Health & Wellness Vocabulary Discovery of DNAOther quiz:
Microbiology › ViewWhich of the following statements does not represent the role of a cell marker in the third line of defense?
A. They are attachment sites for foreign molecules.
B. They serve as recognition factors for self and nonself molecules.
C. They receive and transmit signals to coordinate the immune response.
D. They serve as transcription factors to initiate antibody production.
BMS Cell Cycle and Cancer › View
Sister Chromatids separate from each other
A. prophase
B. telophase
C. anaphase
D. metaphase